Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 27 of KALA BIO, Inc.'s SEC filings and found 2 warrant series, 8 convertibles, 1 ATM program, 2 shelf registrations and 4 completed offerings on file for KALA. The latest dilution event on file is a registration statement on Jun 25, 2026. Analysis updated Sep 18, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
ERNAErnexa Therapeutics Inc.
GRIGRI Bio, Inc.
APVOAptevo Therapeutics Inc.
LIMNLiminatus Pharma, Inc. Class A Common Stock
JUNSJupiter Neurosciences, Inc.
PMCBPharmaCyte Biotech, Inc.
DRMADermata Therapeutics, Inc.
SXTP60 Degrees Pharmaceuticals, Inc.
CMNDClearmind Medicine Inc.
CVKDCadrenal Therapeutics, Inc. Common Stock
MDCXMedicus Pharma Ltd. Common Stock
REVBRevelation Biosciences, Inc.
BDRXBiodexa Pharmaceuticals plc American Depositary Shs
CODXCo-Diagnostics, Inc.
ONCOOnconetix, Inc.